FDA approves heart failure treatment Entresto
8 July 2015 | By Victoria White
The US Food and Drug Administration (FDA) has approved Novartis' Entresto (sacubitril/valsartan) tablets for the treatment of heart failure with reduced ejection fraction.
List view / Grid view
News
DSMB recommends continuation of Genticel’s Phase 2 clinical trial of GTL001
8 July 2015 | By Victoria White
Genticel has announced that the independent Data Safety Monitoring Board recommends the continuation, per protocol, of its Phase 2 clinical trial of GTL001...
First-in-class epilepsy treatment Fycompa launches in the UK
8 July 2015 | By Victoria White
Eisai’s Fycompa (perampanel), a once-daily epilepsy treatment that inhibits AMPA receptors, launches in the United Kingdom today...
Serious adverse events rare in healthy volunteers participating in Phase I trials
7 July 2015 | By Victoria White
A new study has found that less than 1% of 11,000 healthy volunteers who participated in 394 Phase I trials for new drugs experienced serious complications...
Celtaxsys gains US clearance for Phase 2 trial of acebilustat in patients with cystic fibrosis
7 July 2015 | By
Celtaxsys has gained clearance from the US FDA to begin a Phase 2 clinical trial of acebilustat in adult patients with cystic fibrosis (CF) in the US...
Pfizer begins Phase 2b study of S. aureus vaccine in adults undergoing elective spinal fusion surgery
7 July 2015 | By Victoria White
The first patients have been enrolled in a Phase 2b clinical trial of Pfizer’s S. aureus vaccine in adults undergoing elective spinal fusion surgery...
Allergan to acquire exclusive worldwide rights to Merck’s CGRP migraine development programme
7 July 2015 | By Victoria White
Allergan is to acquire exclusive worldwide rights to Merck's CGRP receptor antagonists, which are being developed for the treatment of migraine...
Over-the-counter antacid lansoprazole could be an effective anti-tuberculosis drug
7 July 2015 | By Victoria White
Testing thousands of approved drugs, EPFL scientists have found that an over-the-counter antacid, lansoprazole, may be an effective anti-tuberculosis drug...
Vaccine for West Nile virus enters human clinical trials
7 July 2015 | By Victoria White
A new investigational vaccine designed to protect against West Nile Virus infection is being tested in a Phase 1 clinical trial...
Bavarian Nordic receives bulk order for Imvamune smallpox vaccine
7 July 2015 | By Victoria White
BARDA, a division of the US Department of Health & Human Services, has ordered a bulk supply of Bavarian Nordic’s Imvamune non-replicating smallpox vaccine...
Phase III data show significant overall survival benefit of afatinib compared to erlotinib in patients with SCC
6 July 2015 | By Victoria White
Results from the LUX-Lung 8 Trial demonstrate that afatinib resulted in superior progression-free survival and overall survival compared to erlotinib...
Patients with dementia not getting enough help from health and social care services, say GPs
6 July 2015 | By Victoria White
Over three quarters of UK GPs think their patients with dementia rely on family as they do not get enough help from health and social care services...
Allergan to acquire Oculeve dry eye disease development programmes
6 July 2015 | By Victoria White
Allergan is to acquire Oculeve. The acquisition will add novel, complementary dry eye development programmes to Allergan's portfolio...
World Zoonosis Day: Now is the time to take the bite out of rabies
6 July 2015 | By Victoria White
Despite being preventable thanks to vaccines, over 60,000 people die from rabies each year making it one of the world’s most deadly infectious diseases...
Second-line cetuximab active beyond progression in quadruple wild-type patients with mCRC
6 July 2015 | By Victoria White
Results from a study on the efficacy of cetuximab plus FOLFOX chemo as second-line treatment for patients with mCRC were presented at the ESMO 2015 congress...
